Featured Content

Symposia

Advances in the Treatment of Diffuse Large B Cell Lymphoma: ADCs, Bispecific Antibodies, CAR T Therapies and Combinations
Live Virtual Webinar
Saturday, August 24, 2024: 10:00 AM Eastern Time, 9:00 AM Central Time, 8:00 AM Mountain Time, and 7:00 AM Pacific Time
https://www.mycme.com/courses/advances-in-the-treatment-of-diffuse-large-b-cell-lymphoma-9475


Myelofibrosis: Symptom Burden, Risk Stratification and Novel Treatments
Live Virtual Webinar
Saturday, August 10, 2024: 10:00 AM Eastern Time, 9:00 AM Central Time, 8:00 AM Mountain Time, and 7:00 AM Pacific Time
https://www.mycme.com/courses/myelofibrosis-symptom-burden-risk-stratification-and-novel-treatments-9511


Advances in Blood-based Biomarkers and Disease Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Live Virtual Webinar
Saturday, August 3, 2024: 10:00 AM Eastern Time, 9:00 AM Central Time, 8:00 AM Mountain Time, and 7:00 AM Pacific Time
https://www.mycme.com/courses/advances-in-blood-based-biomarkers-and-disease-modifying-anti-amyloid-antibody-therapies-for-early-stage-alzheimers-disease-9380


Ovarian Cancer: Optimizingthe Management Based on Mutations and Biomarkers to Direct Treatment with PARP Inhibitors and Immunotherapy
Live Virtual Webinar
Saturday, June 29, 2024: 10:00 AM Eastern Time, 9:00 AM Central Time, 8:00 AM Mountain Time, and 7:00 AM Pacific Time
https://www.mycme.com/courses/optimizing-the-management-of-ovarian-cancer-to-direct-treatment-with-parp-inhibitors-and-immunotherapy-9384


Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options
Live Virtual Webinar
Saturday, April 27, 2024: 10:00 AM ET / 9:00 AM CT
https://www.mycme.com/courses/understanding-risk-factors-screening-and-treatment-options-in-glaEucoma-management-9315


New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Live Virtual Webinar
Date: Saturday, February 10, 2024, 11:00 AM Eastern Time, 10:00 AM Central Time and 9:00 AM Mountain Time
https://www.mycme.com/courses/new-prospects-in-blood-based-biomarkers-and-disease-modifying-anti-amyloid-antibody-therapies-for-early-stage-alzheimers-disease-9192


Changing Landscape of Diagnosis and Treatment of Multiple Myeloma
Live Virtual Webinar
Saturday, October 28, 2023 at 8:30 AM Eastern
https://www.mycme.com/courses/changing-landscape-of-diagnosis-and-treatment-of-multiple-myeloma-9053


Advances in Symptom Burden, Risk Stratification, and Treatment of Myelofibrosis
Live Virtual Webinar
Wednesday, January 18, 2023, at 7 pm Eastern
https://www.mycme.com/courses/advances-in-symptom-burden-risk-stratification-and-treatment-of-myelofibrosis-8521


New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases
Live Virtual Webinar
Wednesday, November 30, 2022 at 7:00 PM EST
https://www.mycme.com/courses/new-paradigms-in-the-clinical-practice-of-inflammatory-bowel-diseases-live-event-8481

New Webcasts

Ovarian Cancer: Optimizing the Management Based on Mutations and Biomarkers to Direct Treatment with PARP Inhibitors and Immunotherapy
7/10/24 - 7/10/25
https://www.mycme.com/courses/ovarian-cancer-mutations-biomarkers-treatment-parp-inhibitors-immunotherapy-9558


Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options
5/17/24 - 5/15/25
https://www.mycme.com/courses/glaucoma-management-risk-factors-screening-treatment-options-9450


New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease 
2/16/24 - 2/16/25
https://www.mycme.com/courses/biomarkers-anti-amyloid-antibody-therapies-early-stage-alzheimers-disease-9307


Changing Landscape of Diagnosis and Treatment Options for Multiple Myeloma
11/16/23 - 11/16/24
https://www.mycme.com/courses/diagnosis-and-treatment-options-for-multiple-myeloma-9155


Emerging Strategies in the Immune Checkpoint Inhibitors (ICIs) and the Synergistic Effect of Antibody-Drug Conjugate in Combination with ICIs for Urothelial Carcinoma
4/18/23 - 4/18/24
https://www.mycme.com/courses/immune-checkpoint-inhibitors-antibody-drug-combination-urothelial-carcinoma-8758


Sustained-Release Drug Delivery System in the Management of Glaucoma
3/15/23 - 3/15/24
https://www.mycme.com/courses/sustained-release-drug-delivery-system-in-the-management-of-glaucoma-8736


Glaucoma: Sustained-release Drug Delivery System, Topical Agents, and Emerging 3D Visualization Technologies
3/1/23 - 3/1/24
https://www.mycme.com/courses/glaucoma-emerging-therapies-3d-visualization-8660


Hepatocellular Carcinoma: Immune Checkpoint Inhibitors, Multi-Targeted Tyrosine Kinase Inhibitors and the Combination Thereof
2/9/23 - 2/9/24
https://www.mycme.com/courses/novel-therapies-for-hepatocellular-carcinoma-8614